Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Intelligent decision-making systems using wearable electronics and deep learning (DL) might identify Alzheimer's disease (AD) early for treatment. These technologies can continually monitor vital signs and behavioral characteristics to identify early cognitive deterioration in patients. Clinical examinations, neuroimaging, and cognitive testing are the main ways to identify Alzheimer's, but they a...
The aging society urgently requires scalable methods to monitor cognitive decline and identify social and psychological factors indicative of dementia risk in older adults. Our machine learning models captured facial, acoustic, linguistic, and cardiovascular features from 39 older adults with normal cognition or mild cognitive impairment, derived from remote video conversations and quantified thei...
Exploiting deep learning methods to accelerate the analysis of medical images and the interpretation of pathology results for early diagnosis of Alzhe...
BACKGROUND: High-throughput technologies now produce a wide array of omics data, from genomic and transcriptomic profiles to epigenomic and proteomic ...
Behavioural and psychological symptoms of dementia pose challenges to the safety and well-being of individuals in residential care. The integration of...
This study utilized a novel Proximity Barcoding Assay to perform high-resolution proteomic profiling of individual plasma extracellular vesicles from ...
Alzheimer's disease (AD) is an irreversible neurodegenerative disorder. Diffusion tensor imaging (DTI) is widely used to detect brain alterations for ...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that disrupts cognitive function across multiple domains, particularly affecting ...
ObjectiveTo review the application of artificial intelligence (AI) in the care of older adults with disabilities, identifying intervention type, targe...
BACKGROUND: Counseling in family dementia care aims to support caregivers in mastering challenges. The use of information and communication technologi...
Tauopathies are characterised by a progressive accumulation of hyperphosphorylated tau. However, early and intermediate stages remain challenging to q...
Amyloid fibrils formed by the misfolding and aggregation of proteins are a pathological hallmark of many neurodegenerative conditions including Alzhei...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that remains a global challenge due to its complex pathology and the lack of defi...
Vascular Cognitive Impairment and Dementia (VCID), the second most common form of dementia, is becoming increasingly prevalent worldwide. However, cur...
INTRODUCTION: Systemic inflammation has been identified as a key factor in neurodegeneration but the value of circulating inflammatory proteins in dem...
Neurodegenerative diseases (NDDs), including Alzheimer's disease (AD) and Parkinson's disease (PD), are major public health challenges lacking effecti...
Due to the late manifestation of structural symptoms and symptomatic overlap, neurodegenerative diseases such as Parkinson's Disease (PD) and Alzheime...
OBJECTIVES: Given the heterogeneous nature of Alzheimer's Disease (AD) and its higher prevalence in females, it is crucial to understand sex-related d...
For patients with serious illnesses, goals of care conversations improve quality of life and patient and family satisfaction and may reduce healthcare...
Convolutional neural networks (CNNs) are widely recognized for their high precision in image classification. Nevertheless, the lack of transparency in...